Розувастатин и Кверцетин против диабетической нефропатии: синергия защиты почек и ферроптоза?

Diabetes Metab Syndr Obes. 2025 Aug 5;18:2681–2694. doi: 10.2147/DMSO.S524983 A Network Pharmacology-Based Investigation into the Mechanism of Quercetin Combined with Rosuvastatin in Delaying Diabetic Nephropathy via Inhibiting NRK-52E Cell Ferroptosis https://pmc.ncbi.nlm.nih.gov/articles/PMC12335270/